|
2026
|
Invention
|
Method for the reduction of host cell proteins in affinity chromatography.
The current invention... |
|
|
Invention
|
Leveraging large language models for standardizing clinical data.
Disclosed are various embodime... |
|
|
Invention
|
Compositions and methods for treating multiple sclerosis.
The present invention relates to metho... |
|
|
Invention
|
Enzyme and pathway modulation with sulfhydryl compounds and their derivatives.
The present inven... |
|
|
Invention
|
New process for the preparation of fluoropyrrolidine.
The present invention relates to a new pro... |
|
|
Invention
|
Drug combinations screening.
Methods of screening drug combinations are described. The methods c... |
|
|
Invention
|
Multispecific fusion proteins targeting angiogenic and inflammatory factors.
Provided is an anti... |
|
|
Invention
|
Crystalline forms of baxdrostat. The specification generally relates to crystalline forms of baxd... |
|
|
Invention
|
Compounds for the treatment of autoimmune disease. The present invention relates to STING antagon... |
|
|
Invention
|
Nlrp3 inhibiting triazinone compounds. The invention relates to novel compounds having the genera... |
|
|
Invention
|
Screening method. Disclosed herein is a screening method comprising: Providing a capillary (1) an... |
|
|
Invention
|
Assessment of disability in multiple sclerosis. Methods of assessing disease severity in a subjec... |
|
|
Invention
|
Obesity treatment. The invention provides the anti-myostatin antibody GYM329/emugrobart for use i... |
|
|
Invention
|
Apj agonists. The invention provides compounds having the general formula (I) A B (I) wherein A, ... |
|
|
Invention
|
Treatments for multiple sclerosis. The present invention relates to RG6035, a bispecific antibody... |
|
|
Invention
|
A method for the phenotyping of mononuclear cells. The present invention relates to A semi- quant... |
|
|
Invention
|
Method for adopting antibody format to fcrn-mediated recycling. Herein is reported a method for p... |
|
|
Invention
|
New salts and co-crystals. The present invention relates to salts and co-crystals of the compound... |
|
|
Invention
|
Methods of assessing cognitive function. A computer-implemented method of assessing the cognitive... |
|
|
Invention
|
Digital assessment of cognitive function. There is described a computer-implemented method for as... |
|
|
Invention
|
Peptide biomarker for neurological disease, in particular motor neuron disease.
The present inve... |
|
|
Invention
|
Cell culture unit, system, cell culturing arrangement, and method for preparing a membrane in a c... |
|
|
Invention
|
Process of preparing a glp-1r/gipr agonist by coupling peptide fragments. The invention relates t... |
|
|
Invention
|
Double stranded oligonucleotide for modulating myd88 expression. The present invention identifies... |
|
|
Invention
|
Acinetobacter baumannii-calcoaceticus complex infections. The present invention relates to zosura... |
|
|
Invention
|
Methods for treatment of pediatric inflammatory bowel disease with an anti-tl1a antibody. The pre... |
|
|
Invention
|
Drug discovery ecosystem with artificial intelligence agent design infrastructure for dynamic too... |
|
|
Invention
|
Apj agonists. The invention provides compounds having the general formula (I) [Formula should be ... |
|
|
Invention
|
A glp-1 receptor modulator for use in the treatment of metabolic diseases, including diabetes. Th... |
|
|
Invention
|
Device and method for handling biological entities. A device for handling biological entities (1)... |
|
|
Invention
|
Combination therapies for use in the treatment of breast cancer. Provided are combination therapi... |
|
|
Invention
|
Antibodies binding to cd3. The present invention generally relates to antibodies that bind to CD3... |
|
|
Invention
|
Artificial antigen presenting cell line. The present invention provides an artificial antigen pre... |
|
|
Invention
|
Antibiotic macrocyclic peptides. The present invention provides compounds of formula (I); (I) whe... |
|
|
Invention
|
Generation of antibody-derived polypeptides by polypeptide chain exchange.
The present invention... |
|
2025
|
Invention
|
Oligonucleotides for reduction of pd-l1 expression.
The present invention relates to antisense o... |
|
|
Invention
|
Process for the preparation of a fatty acid compound.
The invention relates to a process for the... |
|
|
Invention
|
Bispecific t cell activating antigen binding molecules.
The present invention generally relates ... |
|
|
Invention
|
Dosage of baloxavir marboxil for pediatric patients.
The present invention relates to a method f... |
|
|
Invention
|
Therapy for the treatment of non-hodgkin lymphoma.
Provided herein are methods of treating and/o... |
|
|
Invention
|
Oligonucleotides capable of upregulating glucocerebrosidase expression.
Provided are oligonucleo... |
|
|
Invention
|
Anti-hla-g antibodies and use thereof.
The present invention relates to antibodies that bind to ... |
|
|
Invention
|
Vh-vl interdomain angle based antibody humanization.
Herein is reported a method for selecting o... |
|
2024
|
G/S
|
Antibiotic Preparation |
|
2023
|
Invention
|
Novel imidazopyridine and pyrazolopyridine sulfonamide derivatives.
The invention relates to nov... |
|
|
Invention
|
Heterocyclic-carbonyl-cyclic compounds as magl inhibitors.
The present invention provides compou... |
|
|
Invention
|
Fluorescent probes for magl.
The invention provides compounds having the general formula (I) whe... |
|
|
Invention
|
Crystalline forms of a macrocyclic peptide antibiotic.
Described herein are the mono hydrochlori... |
|
|
Invention
|
Benzamide compounds for treatment of bacterial infections.
The present invention relates to comp... |
|
2022
|
G/S
|
Online-information services, namely, providing on-line information about accessing computer netwo... |
|
2019
|
G/S
|
Medical and scientific research in the field of diabetes; Consultation pertaining to pharmacology... |
|
2017
|
G/S
|
laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for th... |
|
|
G/S
|
a full line of in vitro diagnostic agent, namely, reagents, control solutions for calibrating and... |
|
|
G/S
|
medical diagnostic test strips for determining the level of glucose in blood for medical and clin... |
|
|
G/S
|
blood glucose monitors for medical purposes, lancet devices, lancets; insulin delivery devices an... |
|
2008
|
G/S
|
full line of pharmaceutical preparations |
|
|
G/S
|
pharmaceutical antiviral preparation |
|
2000
|
G/S
|
[ Chemical products, namely, diagnostic preparations for scientific or medical research use; cont... |
|
1999
|
G/S
|
providing information about a pharmaceutical company and its products and services via a web site... |
|
1997
|
G/S
|
pharmaceutical preparation, namely, an anticancer drug |
|
1994
|
G/S
|
pharmaceutical preparation; namely, an antiviral |
|
1993
|
G/S
|
pharmaceutical preparation, namely an immunosuppressive agent |
|
1985
|
G/S
|
COMPUTERS AND ELECTRONIC LABORATORY TESTING APPARATUS USED FOR ANALYSIS OF BIOLOGICAL FLUIDS, PHA... |
|
1984
|
G/S
|
Clinical Laboratory Services |
|
1977
|
G/S
|
[ PROVIDING COMPUTER SCORED PSYCHIATRIC AND PSYCHOLOGICAL TESTING SERVICES; ] PROVIDING PHARMACEU... |
|
|
G/S
|
MEDICAL BOOKLETS AND PAMPHLETS |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS FOR HUMAN [AND VETERINARY] USE |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS[; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE C... |
|
|
G/S
|
IN VITRO DIAGNOSTIC REAGENTS [ ; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE... |
|
1949
|
G/S
|
[ AGENTS USED IN ALLERGY, ANALGESICS, ANALEPTICS, ] ANTI-INFECTIVES [, ANTISPASMODICS ANESTHETIC... |
|
1897
|
G/S
|
CHEMICAL PRODUCTS FOR USE IN MEDICINE AND PHARMACY [ , DISINFECTANTS, AND PERFUMES ] |
